epivir

Generic: lamivudine

Labeler: viiv healthcare company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name epivir
Generic Name lamivudine
Labeler viiv healthcare company
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

lamivudine 300 mg/1

Manufacturer
ViiV Healthcare Company

Identifiers & Regulatory

Product NDC 49702-204
Product ID 49702-204_3d326658-e562-4d27-a0ad-ca2017db2e49
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020564
Listing Expiration 2026-12-31
Marketing Start 2010-10-04

Pharmacologic Class

Established (EPC)
hepatitis b virus nucleoside analog reverse transcriptase inhibitor [epc] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49702204
Hyphenated Format 49702-204

Supplemental Identifiers

RxCUI
152931 152932 199147 199148 349491 352230
UPC
0349702204133 0349702203181
UNII
2T8Q726O95
NUI
N0000175656 N0000175462 N0000009947

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name epivir (source: ndc)
Generic Name lamivudine (source: ndc)
Application Number NDA020564 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (49702-204-13)
source: ndc

Packages (1)

49702-204-13 30 TABLET, FILM COATED in 1 BOTTLE (49702-204-13)

Ingredients (1)

lamivudine (300 mg/1)

Linked Drug Pages (1)

EPIVIR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3d326658-e562-4d27-a0ad-ca2017db2e49", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0349702204133", "0349702203181"], "unii": ["2T8Q726O95"], "rxcui": ["152931", "152932", "199147", "199148", "349491", "352230"], "spl_set_id": ["89226149-47fa-4f7d-bb1f-1aa7034486b8"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-204-13)", "package_ndc": "49702-204-13", "marketing_start_date": "20101004"}], "brand_name": "EPIVIR", "product_id": "49702-204_3d326658-e562-4d27-a0ad-ca2017db2e49", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "49702-204", "generic_name": "lamivudine", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EPIVIR", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "300 mg/1"}], "application_number": "NDA020564", "marketing_category": "NDA", "marketing_start_date": "20101004", "listing_expiration_date": "20261231"}